Interactions between multiple sclerosis and pregnancy. Current landscape of approved treatments
![PDF] Revealing Vascular Abnormalities and Measuring Small Vessel Density in Multiple Sclerosis Lesions using USPIO](https://i1.rgstatic.net/publication/347376838_Revealing_Vascular_Abnormalities_and_Measuring_Small_Vessel_Density_in_Multiple_Sclerosis_Lesions_using_USPIO/links/5ff06bcb299bf1408865785b/largepreview.png "PDF] Revealing Vascular Abnormalities and Measuring Small Vessel Density in Multiple Sclerosis Lesions using USPIO")
PDF] Revealing Vascular Abnormalities and Measuring Small Vessel Density in Multiple Sclerosis Lesions using USPIO
An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview | SpringerLink
MS Minute: Multiple Sclerosis & the Gut Microbiome - Practical Neurology
Multiple Sclerosis: Causes, Symptoms & Natural Support Strategies
Frontiers | Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Supplementary motor area connectivity and dual-task walking variability in multiple sclerosis - Journal of the Neurological Sciences
Multiple Sclerosis: Causes, Symptoms & Natural Support Strategies
Posterior Reversible Encephalopathy Syndrome, Multiple Sclerosis and interferon therapy: Association, co-incidence or convoluted interplay? - Multiple Sclerosis and Related Disorders
Vitamin D3 supplementation in multiple sclerosis: Symptoms and biomarkers of depression - Journal of the Neurological Sciences
ENT-MS-12 questionnaire: A novel tool to investigate otolaryngology symptoms in patients with relapsing-remitting multiple sclerosis. Results from a pilot study - Multiple Sclerosis and Related Disorders
Complete Freund's adjuvant-free experimental autoimmune encephalomyelitis in Dark Agouti rats is a valuable tool for multiple sclerosis studies - ScienceDirect
Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression - ScienceDirect
Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis - Journal of Neuroimmunology
IJMS | Free Full-Text | Current and Future Biomarkers in Multiple Sclerosis | HTML
PB - Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues - The Lancet Neurology
Current Issues in Multiple Sclerosis: Selected Highlights of the ECTRIMS 2018 Congress - European Medical Journal
PDF) An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview
Inflammatory mechanisms underlying cortical injury in progressive multiple sclerosis
Validating the walking while talking test to measure motor, cognitive, and dual-task performance in ambulatory individuals with multiple sclerosis - Multiple Sclerosis and Related Disorders
Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model | Scientific Reports
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target | PNAS
